From: Seroprevalence of hepatitis C and associated risk factors in urban areas of Antananarivo, Madagascar
Age group (years) | P value | ||||
---|---|---|---|---|---|
0 – 24 yrs (n = 1018) | 25 – 44 yrs (n = 688) | 45 – 64 yrs (n = 372) | > 64 yrs (n = 91) | ||
Anti-HCV positive | 1 (0.1) | 7 (1.2) | 10 (2.7) | 7 (7.7) | <10-2 |
HCV RNA positive | 0 (0.0) | 2 (0.3) | 8 (2.2) | 7 (7.7) | <10-2 |
Previous therapeutic injections | 756 (74.3) | 607 (88.3) | 348 (93.5) | 86 (94.5) | <10-2 |
Previous blood transfusion | 11 (2.1) | 52 (7.6) | 58 (15.6) | 10 (10.9) | <10-2 |
Previous dental treatment | 442 (43.5) | 528 (76.8) | 300 (81.1) | 66 (72.5) | <10-2 |
ALT abnormal | 20 (1.9) | 17 (2.5) | 11 (2.9) | 2 (2.2) | <10-2 |
AST abnormal | 152 (14.9) | 63 (9.1) | 53 (14.2) | 11 (12.1) | <10-2 |